EV/EBITDA
N/A
31 min ago
Summary
- APTO EV/EBITDA is not available.
Performance
APTO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
APTO EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | - | - | +7.3% |
| 1 m1 month | - | - | -39.4% |
| 3 m3 months | - | - | -42.5% |
| 6 m6 months | - | - | -69.7% |
| ytdytd | - | - | -52.5% |
| 1 y1 year | - | - | -93.3% |
| 5 y5 years | - | - | -99.9% |
APTO EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | ||||
| 3 m | 3-month | ||||
| 6 m | 6-month | 0.03 | 0.00 | ||
| 1 y | 1-year | 0.03 | -0.41 | ||
| 3 y | 3-year | 0.03 | -1.65 | ||
| 5 y | 5-year | 0.03 | -20.50 | ||
| alltime | all time | 61.22 | -608.04 |
Aptose Biosciences EV/EBITDA History
| Date | Value |
|---|---|
| 2023 | -0.23(-46.5%) |
| 2022 | -0.43(-67.7%) |
| 2021 | -1.33(-73.1%) |
| 2020 | -4.95(-63.2%) |
| 2019 | -13.46(+579.8%) |
| 2018 | -1.98(-54.7%) |
| 2017 | -4.37(+350.5%) |
| 2016 | -0.97(-47.6%) |
| 2015 | -1.85(-52.6%) |
| 2013 | -3.90(+87.5%) |
| 2012 | -2.08(+264.9%) |
| Date | Value |
|---|---|
| 2011 | -0.57(-75.9%) |
| 2010 | -2.37(-12.9%) |
| 2009 | -2.72(+94.3%) |
| 2008 | -1.40(-78.4%) |
| 2007 | -6.47(+10.2%) |
| 2006 | -5.87(+88.1%) |
| 2005 | -3.12(-39.9%) |
| 2004 | -5.19(-90.9%) |
| 2003 | -56.92(+927.4%) |
| 2002 | -5.54(-53.9%) |
| 2001 | -12.02(-48.3%) |
| 2000 | -23.26 |
FAQ
- What is the all time high EV/EBITDA for Aptose Biosciences?
What is the all time high EV/EBITDA for Aptose Biosciences?
Aptose Biosciences all-time high EV/EBITDA is 61.22